SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/E68D6EFC3ED16C1D834B112907DD40A543096105B650EFFC432A9A14385B45C8C44A8B96DBB2D7976904E569D23C0F2A>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/E68D6EFC3ED16C1D834B112907DD40A543096105B650EFFC432A9A14385B45C8C44A8B96DBB2D7976904E569D23C0F2A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E68D6EFC3ED16C1D834B112907DD40A543096105B650EFFC432A9A14385B45C8C44A8B96DBB2D7976904E569D23C0F2A
http://www.w3.org/2000/01/rdf-schema#comment
"the mechanisms responsible for the angiogenic imbalance and the response to anti-VEGF therapy differ between Eng and Alk1 heterozygous mice and raise the need for systemic monitoring of anti-angiogenic therapy effects in HHT patients."
xsd:string
http://purl.uniprot.org/uniprot/#_F723472E2AACD5A3B1B272885FE1001A8EC4DDA6D0F47C19F65C1FD172D513C35DD39B2E7E5CF6324D9BAABE2530ABEC
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/E68D6EFC3ED16C1D834B112907DD40A543096105B650EFFC432A9A14385B45C8C44A8B96DBB2D7976904E569D23C0F2A
http://purl.uniprot.org/uniprot/A9Z1A0
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E68D6EFC3ED16C1D834B112907DD40A543096105B650EFFC432A9A14385B45C8C44A8B96DBB2D7976904E569D23C0F2A
http://purl.uniprot.org/uniprot/#_A9Z1A0-mappedCitation-24061911
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E68D6EFC3ED16C1D834B112907DD40A543096105B650EFFC432A9A14385B45C8C44A8B96DBB2D7976904E569D23C0F2A